Figure 3
Figure 3. Outcome of CN-AML patients 60 years of age or older with respect to MN1 expression within the ELN Favorable and ELN Intermediate-I genetic groups. (A) OS. (B) EFS.

Outcome of CN-AML patients 60 years of age or older with respect to MN1 expression within the ELN Favorable and ELN Intermediate-I genetic groups. (A) OS. (B) EFS.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal